Skip to content

SLXNW

Silexion Therapeutics Corp.

NASDAQ · Healthcare · Biotechnology · IL

$0.01
−2.21%
Ask drillr

Next report

Analyst consensus

Next report date
Nov 18, 2026
EPS estimate
-$9.10
Revenue estimate

Latest reported

Last report date
Aug 14, 2026
EPS actual
-$5.17
EPS estimate
-$21
Revenue actual
Revenue estimate

Track record

Trailing twelve quarters

EPS beats (12Q)
3
EPS misses (12Q)
2
EPS in line (12Q)
0
Avg surprise (4Q)
+24.8%
Revenue beats (12Q)
Earnings call history

No earnings call summaries available

Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 14, 2026-$21-$5.17Beat 75.61%
May 18, 2026-$1.29-$0.85Beat 34.11%
Mar 17, 2026-$1.12-$1.41Miss -25.99%
Nov 12, 2025-$3.40-$2.88Beat 15.30%
Aug 12, 2025-$3.15-$4.32Miss -37.11%

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 18, 2026